Skip to main content
editorial
. 2018 Feb 9;9(2):441–447. doi: 10.1007/s13300-018-0376-6

Table 3.

Factors affecting choice of initial therapy in restless legs symptoms

RLS symptomatology
 Associated insomnia
 Painful restless legs
 Doubtful diagnosis of RLS vs DPN
 Severe symptoms
 Refractory symptoms
α2δ ligand (gabapentin enacarbil)
α2δ ligand
α2δ ligand
Dopaminergic agonist (pramipexole, rotigotine)
Oxycodone, naloxone
Comorbid conditions
 Overweight
 Metabolic syndrome
 Depression
 Generalized anxiety disorder
 Nephropathy
 Osteoporosis
Dopaminergic agonist
Dopaminergic agonist
Dopaminergic agonist
α2δ ligand/consider iron
Ropinirole
α2δ ligand